Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)
Clinical trial NCT04326023 · COMPLETED
Trial details
- NCT number
- NCT04326023
- Sponsor
- University Hospital, Caen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-09
- Primary completion
- 2020-03-18
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.